Posted On: 06/12/2014 1:25:43 AM
Post# of 30066
Stickied post on the IH board:
And the Unlicensed Doctor of Osteopathic Medicine (UDOM) can't seem to locate the source. LMAO
http://content.stockpr.com/amarantus/media/3b...121792.pdf
That guy couldn't find his own testicles without asking someone for help. It's no wonder the Maryland medical review board reached the conclusion of "incompetent to practice medicine" in their ruling.
Quote:
Current Milestones and Catalysts
LymPro
• Pilot clinical performance data (1H-14);
• Retrospective / prognostic 9 year patient record clinical study (1H-14);
• Clinical Performance studies to support CLIA registration (1H-14);
• Commercial Launch as a Laboratory-Developed Test (“LDT”) under CLIA (2H- 2014);
Eltoprazine
• Evaluate best indication for commercial development (1H/14)
• Initiate Phase 2b Clinical Trial (1H/14)
MANF
• Retinitis Pigmentosa: functional genetic mouse model (1H-14)
• Parkinson’s disease: CED delivery data w/Renishaw (1H-14)
• Preliminary systemic toxicology (PK/PD relationship) (1H-14)
• Wolfram Syndrome enablement (Diabetes)
And the Unlicensed Doctor of Osteopathic Medicine (UDOM) can't seem to locate the source. LMAO
Quote:LMAO. Seriously, he thinks he provides the best DD on the IH AMBS board? LMAO again. I found the link to the source in 15 seconds. It's on the company web site, Investors / Presentations section, latest presentation listed, page 5 (the very FIRST place I looked).
Seriously, where did you get those milestones? Could you provide a link?
http://content.stockpr.com/amarantus/media/3b...121792.pdf
That guy couldn't find his own testicles without asking someone for help. It's no wonder the Maryland medical review board reached the conclusion of "incompetent to practice medicine" in their ruling.
(0)
(0)
The truth is incontrovertible. Malice may attack it, ignorance may deride it, or a narcissistic board moderator may delete it because it doesn't support his disjointed thinking, but in the end, there it is.
– Windbag Duckbill
– Windbag Duckbill
